Events

There are currently no events scheduled. Please check back soon.

Press Releases

May 08, 2009
Teikoku Pharma USA Acquires Travanti Pharma Inc.

March 09, 2009
Teikoku Pharma USA and Eisai Co., Ltd Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil.

February 25, 2009
Teikoku Enters into an Agreement with Eisai for the Development of a Transdermal Patch Formulation of Donepezil Hydrochloride

February 27, 2007
Teikoku Pharma Announces Contract with Dermatrends to Study Transdermal Application of Anti-Psychotic Drug

January 10, 2007
Versatis®, Ldocaine Medicated Plaster Approved by MHRA

February 01, 2006
Teikoku Enters into an Agreement with Altea Therapeutics for the Development, Manufacture, and Commercialization in Japan of a New Transdermal Therapy for Parkinson's Disease

January 11, 2006
Teikoku Seiyaku lLcenses rRghts to Develop and Market LAB Pharma’s Fentanyl Taifun in Japan

October 18, 2005
Teikoku Pharma USA and SK Chemicals Sign Agreement to Distribute Teikoku Pharma’s Lidocaine Hydrogel Patch

March 31, 2005
Study Compares Lidoderm Patch and Celebrex for Osteoarthritis Pain

December 02, 2004
Teikoku Pharma Expands Manufacturing Capabilities to the United States